Illinois quick hits: Poll finds mixed reviews for Trump; posthumous medal for Kirk; transit fare increase proposed
Poll finds mixed reviews for Trump
President Donald Trump’s economic policies are getting mixed reviews from voters.
The Center Square Voters’ Voice Poll, conducted by Noble Predictive Insights, surveyed 2,565 registered voters from Oct. 2-6.
The poll found that 51% of voters disapproved or strongly disapproved of Trump’s handling of the U.S. economy.
About 47% of voters approved or strongly approved and about 3% said they were not sure.
Posthumous medal for Illinois-native Kirk
President Donald Trump is scheduled to award the Presidential Medal of Freedom to the late Charlie Kirk at a White House ceremony Tuesday afternoon.
The Turning Point USA founder and Illinois native was fatally shot Sept. 10 in Utah.
The award comes on what would have been Kirk’s 32nd birthday.
Transit fare increase proposed
The Chicago Transit Authority has joined Metra and Pace in proposing higher fares in next year’s operating budget.
The CTA released three different budget scenarios to plan for what transit action, if any, the Illinois General Assembly might take during fall veto session.
All three plans include a 25-cent increase for bus and rail fares along with price hikes for one-day and multi-day passes.
Latest News Stories
Manhattan Board Approves Kubota RTV Purchase for Sidewalk Plowing
Hegseth promises to fix barracks, but work could take time
‘Long overdue’: Praise for HHS’ action to bar taxpayer-funded sex-change procedures
Gas prices drop, but taxes make Illinois pricier than Midwest neighbors
Liquor License Amendments Approved for Frankfort, Joliet, and Lockport Businesses
Meeting Summary and Briefs: Will County Planning and Zoning Commission for December 16, 2025
Joliet Property Owner Cleared to Convert Non-Conforming Building into Two-Unit Residence
Colorado adopts first-of-its-kind water protections in U.S.
Epstein files redactions frustrate lawmakers
Supreme Court weighs gun owners’ challenge to IL transit carry ban
Nine pharmaceutical companies agree to most-favored-nation pricing
Congress leaves for holidays after zero progress on federal funding